In contrast to classic GR ligands, a specific breast cancer–associated cholesterol metabolite (6-oxo-cholestan-3β,5α-diol or OCDO) may shift the role of GR toward oncogenesis [94]. The gene discussed is NR3C1; the disease is breast carcinoma.